Jane Street Group, LLC Amicus Therapeutics, Inc. Call Options Transaction History

Jane Street Group, LLC

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 17, 2022	BUY	$7.89 - $12.48 $171,213 - $270,816	21,700 Added 70.0%	52,700 $499,000
Q4 2021 Feb 15, 2022	SELL	$9.82 - $12.44 $23,568 - $29,856	-2,400 Reduced 7.19%	31,000 $358,000
Q3 2021 Nov 16, 2021	SELL	$8.74 - $11.84 $214,130 - $290,080	-24,500 Reduced 42.31%	33,400 $319,000
Q2 2021 Aug 16, 2021	SELL	$8.71 - $10.72 $1.02 Million - $1.26 Million	-117,100 Reduced 66.91%	57,900 $558,000
Q1 2021 May 18, 2021	BUY	$9.2 - $23.86 $1.03 Million - $2.67 Million	111,800 Added 176.9%	175,000 $1.73 Million
Q4 2020 Feb 17, 2021	SELL	$13.47 - $24.89 $1.1 Million - $2.02 Million	-81,300 Reduced 56.26%	63,200 $1.46 Million
Q3 2020 Nov 17, 2020	SELL	$12.89 - $15.89 $737,308 - $908,908	-57,200 Reduced 28.36%	144,500 $2.04 Million
Q2 2020 Aug 17, 2020	BUY	$8.86 - $15.69 $1.58 Million - $2.8 Million	178,600 Added 773.16%	201,700 $3.04 Million
Q3 2018 Nov 14, 2018	BUY	$11.6 - $16.54 $126,440 - $180,286	10,900 Added 89.34%	23,100 $279,000
Q2 2018 Aug 15, 2018	SELL	$13.13 - $17.09 $40,703 - $52,979	-3,100 Reduced 20.26%	12,200 $191,000
Q4 2017 Feb 15, 2018	SELL	$12.51 - $16.24 $3,753 - $4,871	-300 Reduced 1.92%	15,300 $220,000
Q3 2017 Nov 14, 2017	BUY	$11.74 - $15.78 $183,144 - $246,168	15,600	15,600 $235,000

288

321M

260K

261K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $3.08B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.